CYP1A1 and malignant hypertension: We provided evidence that the intrarenal EETs deficiency significantly contributes to the impairment of renal function and the development and maintenance of malignant hypertension in I3C-induced Cyp1a1-Ren-2 transgenic rats [43–45].